Harnessing host–virus evolution in antiviral therapy and immunotherapy
Abstract Pathogen resistance and development costs are major challenges in current approaches to antiviral therapy. The high error rate of RNA synthesis and reverse‐transcription confers genome plasticity, enabling the remarkable adaptability of RNA viruses to antiviral intervention. However, this p...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wiley
2019-01-01
|
| Schriftenreihe: | Clinical & Translational Immunology |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1002/cti2.1067 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|